The efficacy of voglibose on glycemic excursions in non-insulin-treated NIDDM patients -: Response -: Protection of the pancreatic β-cells by an α-glucosidase inhibitor

被引:1
作者
Matsumoto, K [1 ]
Yano, M [1 ]
Ueki, Y [1 ]
Miyake, S [1 ]
Tominaga, Y [1 ]
机构
[1] Sasebo Chuou Hosp, Dept Internal Med, Sasebo, Nagasaki 8571195, Japan
关键词
D O I
10.2337/diacare.21.7.1206b
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1206 / 1207
页数:2
相关论文
共 5 条
[1]   REDUCTION OF GLYCOSYLATED HEMOGLOBIN AND POSTPRANDIAL HYPERGLYCEMIA BY ACARBOSE IN PATIENTS WITH NIDDM - A PLACEBO-CONTROLLED DOSE-COMPARISON STUDY [J].
CONIFF, RF ;
SHAPIRO, JA ;
ROBBINS, D ;
KLEINFIELD, R ;
SEATON, TB ;
BEISSWENGER, P ;
MCGILL, JB .
DIABETES CARE, 1995, 18 (06) :817-824
[2]   EFFECTS OF THE CARBOHYDRASE INHIBITOR MIGLITOL IN SULFONYLUREA-TREATED NIDDM PATIENTS [J].
JOHNSTON, PS ;
SANTIAGO, JV ;
CONIFF, RF ;
PISUNYER, FX ;
HOOGWERF, BJ ;
KROL, A .
DIABETES CARE, 1994, 17 (01) :20-29
[3]   Meningeal architecture of the cavernous sinus: Clinical and surgical implications [J].
Kawase, T ;
vanLoveren, H ;
Keller, JT ;
Tew, JM .
NEUROSURGERY, 1996, 39 (03) :527-534
[4]   Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients [J].
Matsumoto, K ;
Yano, M ;
Miyake, S ;
Ueki, Y ;
Yamaguchi, Y ;
Akazawa, S ;
Tominaga, Y .
DIABETES CARE, 1998, 21 (02) :256-260
[5]  
Yoshioka K, 1998, DIABETES CARE, V21, P1206, DOI 10.2337/diacare.21.7.1206